M Li, W Guo, Y Dong, X Wang, D Dai, X Liu… - Frontiers in …, 2020 - frontiersin.org
Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) induced Coronavirus Disease 2019 (COVID-19) has posed a global threat to public health. The …
K Mukund, P Nayak, C Ashokkumar, S Rao… - Frontiers in …, 2021 - frontiersin.org
The mechanisms underlying the immune remodeling and severity response in coronavirus disease 2019 (COVID-19) are yet to be fully elucidated. Our comprehensive integrative …
The global outbreak of coronavirus-2019 (COVID-19) still claims more lives daily around the world due to the lack of a definitive treatment and the rapid tendency of virus to mutate …
M Zheng, Y Gao, G Wang, G Song, S Liu… - Cellular & molecular …, 2020 - nature.com
In December 2019, a novel coronavirus was first reported in Wuhan, China. 1 It was named by the World Health Organization as severe acute respiratory syndrome coronavirus 2 …
The relationship between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and host immunity is poorly understood. We performed an extensive analysis of immune …
INTRODUCTION Many patients with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, present with …
With a rising incidence of COVID-19–associated morbidity and mortality worldwide, it is critical to elucidate the innate and adaptive immune responses that drive disease severity …
L Kuri-Cervantes, MB Pampena, W Meng… - Science …, 2020 - science.org
Although critical illness has been associated with SARS-CoV-2–induced hyperinflammation, the immune correlates of severe COVID-19 remain unclear. Here, we comprehensively …
M García, E Kokkinou… - Clinical & …, 2020 - Wiley Online Library
Objectives The role of innate lymphoid cells (ILCs) in coronavirus disease 2019 (COVID‐ 19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is …